http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102772675-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17a8e4e0f34cc238958b623cd69d3d22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate | 2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8476aaaaad7bde9e1547f03b5afef988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a53853719d2395f4827a913dd25471c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c7cbc2d8b748f981d6b74bfeb7e227a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb97674639896f17ea640c51632d7b18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08d296bfee99bd84dcdba557ac67c591 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_731f017580ae666eeb38cd37feb80536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3667660b1ac9e8f144266c5e43d7d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec98b37fc8dd7ddff62a654ea405a34b |
publicationDate | 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102772675-B |
titleOfInvention | Pharmaceutical composition for treating apoplexy hemiplegia and preparation method of pharmaceutical composition |
abstract | The invention relates to a pharmaceutical composition for treating apoplexy hemiplegia and a preparation method of the pharmaceutical composition. The pharmaceutical composition for treating apoplexy hemiplegia selectively comprises astragalus, erigeron breviscapus, hawthorn, bidentate achyranthes, bighead atractylodes rhizome, safflower, red peony roots, Szechuan lovage rhizome, Chinese angelica, cassia twig, leech, tall gastrodia tuber and earthworm. Required formulations prepared by a conventional preparation method by the aid of the modern preparation technology have effects of supplementing qi, activating blood circulation, dispersing blood stasis and dredging collaterals, and are used for treating apoplexy hemiplegia symptoms of hemiplegia, facial paralysis, limbs numbness and the like caused by apoplexy. The pharmaceutical composition for treating apoplexy hemiplegia is applied to clinical treatment and is effective in treatment. |
priorityDate | 2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.